Strategic Partners A/S (CPH:STRAP)
580.00
+10.00 (1.75%)
Jun 19, 2026, 4:59 PM CET
Strategic Partners Market Cap
Strategic Partners has a market cap or net worth of 24.19 million as of June 18, 2026. Its market cap has decreased by -25.78% in one year.
Market Cap
24.19M
Enterprise Value
8.27M
Revenue
309.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
580.00
Market Cap Chart
Since November 21, 2017, Strategic Partners's market cap has decreased from 1.59B to 24.19M, a decrease of -98.48%. That is a compound annual growth rate of -38.62%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 24.19M | -16.91% |
| Dec 30, 2025 | 29.11M | -15.40% |
| Dec 30, 2024 | 34.42M | -26.72% |
| Dec 29, 2023 | 46.96M | 51.14% |
| Dec 30, 2022 | 31.07M | -94.82% |
| Dec 30, 2021 | 599.78M | -74.24% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 21, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.30T |
| Genmab | 100.47B |
| Coloplast | 85.29B |
| ALK-Abelló | 55.39B |
| Gubra | 5.52B |
| BioPorto | 579.28M |
| Pharma Equity Group | 109.50M |
| ViroGates | 94.68M |